Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov.

Similar presentations


Presentation on theme: "Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov."— Presentation transcript:

1 Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov Model  Gihan H. Elsisi, MSc, Randa Eldessouki, MD, Zoltan Kalo, MSc, MD, PhD, Mohamed M. Elmazar, PhD, Ahmed S. Taha, MD, Basma F. Awad, MD, Manal H. El-Hamamsy, PhD  Value in Health Regional Issues  Volume 4, Pages (September 2014) DOI: /j.vhri Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2 Fig. 1 Markov state-transition diagram. Not shown are the transitions to the death state. B, bleeding; R, reoperation; T, thromboembolism. Value in Health Regional Issues 2014 4, 24-30DOI: ( /j.vhri ) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3 Fig. 2 Results of the one-way sensitivity analysis of the incremental costs. RR, relative risk; RRR, relative risk reduction. Value in Health Regional Issues 2014 4, 24-30DOI: ( /j.vhri ) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4 Fig. 3 Results of the one-way sensitivity analysis of the incremental QALYs. QALY, quality-adjusted life-year; RRR, relative risk reduction. Value in Health Regional Issues 2014 4, 24-30DOI: ( /j.vhri ) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions


Download ppt "Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov."

Similar presentations


Ads by Google